Urinary Bag Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Urinary Bag Market is projected to expand from USD 2.55 Billion in 2025 to USD 3.25 Billion by 2031, registering a CAGR of 4.13%. These sterile medical devices are essential for collecting and storing urine for patients suffering from incontinence or recovering from surgery. The market is primarily propelled by a rapidly aging global population and an increasing prevalence of chronic urological conditions that require effective drainage management. For instance, data from the American Urological Association in 2024 indicates that the prevalence of benign prostatic hyperplasia in men aged 65 and older has reached between 29% and 35%. This high incidence rate guarantees sustained demand for urine collection solutions, while rising surgical volumes further strengthen the sector, irrespective of transient design trends.

However, the market encounters significant hurdles due to the elevated risk of infections linked to urinary catheters. To ensure patient safety and mitigate hospital liabilities, healthcare facilities are increasingly adopting strict protocols designed to minimize the duration of catheterization. This clinical transition toward reducing the use of invasive drainage methods restricts the adoption of urinary bags for long-term patient management. Consequently, these safety measures act as a notable constraint on the overall expansion of market volume.

Market Drivers

The rapid growth of the global geriatric population serves as a major driver for market adoption, given the strong correlation between aging, loss of bladder control, and mobility issues. As life expectancy rises, there is a proportional increase in the number of people requiring long-term incontinence solutions, such as urinary bags. According to the Population Reference Bureau's '2024 World Population Data Sheet' from September 2024, the global population aged 65 and over has exceeded 800 million, accounting for roughly 10% of the total population. This demographic evolution ensures a steady and growing patient base that needs reliable urine collection devices regardless of economic fluctuations, encouraging manufacturers to ramp up production for an older demographic susceptible to chronic urological issues.

Furthermore, the increasing preference for home-based healthcare services is accelerating market momentum by moving patient management from clinical facilities to domestic settings. This shift fuels the demand for discreet, easy-to-use urinary bags that support self-care and enhance the quality of life for chronic patients. In its 'Annual Report 2023/24' published in November 2024, Coloplast reported that its Continence Care division achieved an organic growth rate of 8%, highlighting the strong demand for chronic care products outside of hospitals. This trend is also supported by the prevalence of conditions needing surgical care; the American Cancer Society estimated 83,190 new urinary bladder cancer diagnoses in the United States in 2024, maintaining the need for post-operative drainage systems in both acute and home care environments.

Market Challenges

The expansion of the Global Urinary Bag Market is primarily hindered by the high risk of catheter-associated urinary tract infections (CAUTIs). This clinical danger has compelled healthcare providers to fundamentally revise their care strategies, prioritizing the early removal of indwelling catheters to reduce hospital liabilities. Since urinary bags are consumable items directly linked to the length of catheterization, rigorous hospital protocols that curtail usage duration directly decrease recurring sales for manufacturers. Consequently, the market faces restrictions as medical facilities switch patients to alternative, non-invasive incontinence management techniques to circumvent the serious financial and reputational repercussions associated with hospital-acquired conditions.

The effect of these exclusionary practices is reflected in recent industry metrics that establish a link between safety protocols and diminished device utilization. The Leapfrog Group reported a 36% decrease in catheter-associated urinary tract infections across monitored facilities in 2024. This substantial statistical decline indicates a successful industry-wide initiative to reduce dependence on invasive urinary devices. Although this trend benefits patient safety, it signifies a considerable reduction in total catheter days, thereby acting as a significant restraint on the volume growth of consumables within the urinary bag sector.

Market Trends

The Global Urinary Bag Market is being transformed by the adoption of biodegradable and eco-friendly materials, as manufacturers align with environmental sustainability targets to cut down on medical plastic waste. Major medical device companies are steadily shifting away from traditional polyvinyl chloride (PVC) and single-use plastics in favor of renewable, bio-based polymers and recyclable alternatives that preserve clinical sterility while lowering ecological impact. This transition is propelled by regulatory demands and healthcare procurement policies that favor low-carbon supply chains, forcing the industry to innovate its production processes. For example, Coloplast's 'Annual Report 2024/25' from November 2025 notes that the company increased its production waste recycling rate to 83%, exceeding its 75% goal and emphasizing the rapid shift toward circular manufacturing in the continence care sector.

At the same time, there is an accelerated move toward single-use disposable systems aimed at infection prevention, incorporating advanced antimicrobial technologies directly into drainage products. To fight catheter-associated urinary tract infections (CAUTIs), the market is advancing from standard drainage bags to complex, closed-system solutions equipped with anti-infective coatings and improved valves to stop bacterial migration. This trend is demonstrated by the commercial growth of infection-preventing technologies through strategic alliances. In February 2025, Bactiguard Holding AB reported in its 'Year-end report 2024' that license revenues from its partnership with Becton, Dickinson and Company (BD) rose by 33.9% to SEK 124.7 million, highlighting the increasing adoption of coated urinary devices meant to improve patient safety.

Key Players Profiled in the Urinary Bag Market

• ConvaTec, Inc.
• Cardinal Health
• Teleflex, Inc.
• Coloplast
• McKesson Medical Surgical, Inc.
• Amsino International, Inc.
• Flexicare Medical Ltd.
• Medline Industries, Inc.
• Manfred Sauer GmbH
• Romsons Group

Report Scope

In this report, the Global Urinary Bag Market has been segmented into the following categories:

Urinary Bag Market, by Product:

• Large Bags
• Leg Bags

Urinary Bag Market, by Usage:

• Reusable
• Disposable

Urinary Bag Market, by Capacity:

• 0-500 ml
• 500-1000 ml
• 1000-2000 ml

Urinary Bag Market, by End Use:

• Hospitals
• Clinics
• Others

Urinary Bag Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Urinary Bag Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.